A Phase 3, Randomized, Controlled, and Blinded Clinical Trial to Evaluate Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine for Infants and Other Age Groups.
Phase of Trial: Phase III
Latest Information Update: 09 Jul 2015
At a glance
- Drugs Hepatitis B vaccine-Beijing Tiantan Biological Products Co. (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacodynamics
- 09 Jul 2015 New trial record